Growth in this market is majorly attributed to factors such as increasing demand for pet insurance and rising animal healthcare expenditure, growing demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels.
What the Market Looks Like?
Predicted to grow at a CAGR of 5.8% during the forecast period, the global US Veterinary Infusion Pumps marketis estimated to reach USD 35.4 Million by the end of 2021.
“Large-volume infusion pumps account for the largest share of the U.S. veterinary infusion pumps market”
Large-volume infusion pumps account for the largest share of the U.S. veterinary infusion pumps market and are expected to witness the highest growth over the next five years. The high growth in this segment can be attributed to the growing use of these pumps to deliver large volumes of fluids in animals during emergency conditions, provide blood transfusions, and administer total parenteral nutrition at continuous predetermined medium-to-high flow rates.
“Private hospitals accounted for the largest share”
In the end-user market, private hospitals accounted for the largest share, majorly due to the increasing use of large-volume infusion pumps and syringe infusion pumps to administer fluids for various clinical conditions in animals, and growth in animal health expenditure.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160422967
Leading market players
The prominent players in the US Veterinary Infusion Pumps market include Heska Corporation (U.S.), Digicare Biomedical Technology Inc. (U.S.), B. Braun Melsungen AG (Germany), Q Core Medical Ltd. (Israel), Grady Medical System Inc. (U.S.), Mediaid Inc. (U.S.), Burtons Medical Equipment Ltd. (U.K.), Jørgen Kruuse A/S (Denmark), and Kent Scientific Corporation (U.S.).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=160422967